In this ceRNA network, we found that TIMP2 was a potential target of hsa-miR-200b/c-3p, serving as a natural inhibitor of the matrix metalloproteinases and a potential non-invasive biomarker in kidney cancer and lung cancer. This evidence concerns the gene TIMP2 and lung carcinoma.